Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South.
Colasanti JA, Aldredge A, Niles-Carnes LV, Ochieng E, Pareek P, Robinson V, Anderson E, Castaneda M, Spralling H, Smith BL, Sumitani J, Paul Leue E, Moran CA, Lora M, Armstrong WS, Collins LF.
Colasanti JA, et al. Among authors: lora m.
Clin Infect Dis. 2025 Aug 1:ciaf425. doi: 10.1093/cid/ciaf425. Online ahead of print.
Clin Infect Dis. 2025.
PMID: 40747944